MedPath

LAURUS GENERICS SA (PTY) LTD

🇿🇦South Africa
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

TGA:16

Drug Approvals

IFINWIL eflornithine (as hydrochloride) 192 mg tablet bottle (445692)

Product Name
IFINWIL eflornithine (as hydrochloride) 192 mg tablet bottle
Approval Date
Apr 11, 2025
TGA

ANGUSTA misoprostol 25 microgram tablet blister pack (381571)

Product Name
ANGUSTA misoprostol 25 microgram tablet blister pack
Approval Date
Dec 20, 2022
TGA

FERACCRU iron 30 mg (as ferric maltol) capsule, bottle (355993)

Product Name
FERACCRU iron 30 mg (as ferric maltol) capsule, bottle
Approval Date
Mar 2, 2021
TGA

PLENVU powder for oral liquid sachet composite pack (298344)

Product Name
PLENVU powder for oral liquid sachet composite pack
Approval Date
Jan 9, 2018
TGA

MOVICOL Ready to Take oral solution sachet (274936)

Product Name
MOVICOL Ready to Take oral solution sachet
Approval Date
May 3, 2016
TGA

XIFAXAN rifaximin 200 mg film-coated tablet blister pack (222643)

Product Name
XIFAXAN rifaximin 200 mg film-coated tablet blister pack
Approval Date
May 26, 2015
TGA

MOVICOL LIQUID ORANGE FLAVOUR oral liquid concentrate bottle (212114)

Product Name
MOVICOL LIQUID ORANGE FLAVOUR oral liquid concentrate bottle
Approval Date
Jul 11, 2013
TGA

MOVICOL JUNIOR CHOCOLATE FLAVOUR powder for oral solution sachet (207698)

Product Name
MOVICOL JUNIOR CHOCOLATE FLAVOUR powder for oral solution sachet
Approval Date
Apr 3, 2013
TGA

MOVIPREP ORANGE powder for oral solution sachet (206448)

Product Name
MOVIPREP ORANGE powder for oral solution sachet
Approval Date
Feb 27, 2013
TGA

XIFAXAN rifaximin 550 mg tablet blister pack (183411)

Product Name
XIFAXAN rifaximin 550 mg tablet blister pack
Approval Date
May 17, 2012
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.